← All trials
NCT04918797
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 26, 2021
- Primary completion
- Aug 15, 2021
- Completion date
- Jan 25, 2022
- First posted
- Jun 9, 2021
- Last posted
- Jul 2, 2021
- Enrollment
- 525
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Bharat Biotech International LimitedLead sponsor
- All India Institute of Medical SciencesOverall official - principal investigator
- Cheluvambha Hospital,MysoreOverall official - principal investigator
- Victoria Government HospitalOverall official - principal investigator
- JLN Medical college,AjmerOverall official - principal investigator
- Meditrina Institute of Medical Sciences,NagpurOverall official - principal investigator
- Prakhar Hospital, KanpurOverall official - principal investigator
- Pranam Hospitals HyderabadOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.